K.J. Harrison & Partners’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,050	Closed	-$17K	–	238
2022 Q3	$17K	Hold	3,050	–	–	0.01%	174
2022 Q2	$14K	Buy	3,050 +1,167	+62%	+$5.36K	﹤0.01%	206
2022 Q1	$17K	Hold	1,883	–	–	﹤0.01%	290
2021 Q4	$17K	Buy	+1,883	New	+$17K	﹤0.01%	344